NCP 2.0 Repeat Study

NACompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 30, 2020

Primary Completion Date

March 31, 2021

Study Completion Date

August 31, 2021

Conditions
Brain Health
Interventions
DEVICE

NeuroCatch Platform

To elicit the ERP components of interest in this study (N100, P300, N400), proprietary auditory stimulus sequences will be administered using the NeuroCatch™ Platform version 2.0, an investigational medical device. Each sequence consists of tones and word pairs to elicit the various components of interest. Version 2.0 of the NeuroCatch™ Platform consists of a computerized acquisition software which presents the stimulus, acquires the data and presents the amplitude and latency values of the ERP components (N100, N400, P300)

Trial Locations (1)

V3V 0C6

HealthTech Connex Inc. Centre for Neurology Studies, Surrey

All Listed Sponsors
lead

NeuroCatch Inc.

INDUSTRY

NCT04661592 - NCP 2.0 Repeat Study | Biotech Hunter | Biotech Hunter